Zhejiang Chemsyn Pharm Co (BJSE:920656) Marketable Securities: ¥0.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920656 Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
61 GF Score
Price ¥15.28
GF Value ¥19.11
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Zhejiang Chemsyn Pharm Co Marketable Securities?

Zhejiang Chemsyn Pharm Co BJSE:920656 61 Marketable Securities is ¥0.0 Mil as of Jun. 2026. GuruFocus rates BJSE:920656 with a GF Score™ of 61/100 and a GF Value™ of ¥19.11 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Zhejiang Chemsyn Pharm Co's Marketable Securities for the quarter that ended in Jun. 2026 was ¥0.0 Mil.

Zhejiang Chemsyn Pharm Co's annual Marketable Securities stayed the same from Dec. 2023 (¥0.0 Mil) to Dec. 2024 (¥0.0 Mil) but then increased from Dec. 2024 (¥0.0 Mil) to Dec. 2025 (¥55.2 Mil).

Zhejiang Chemsyn Pharm Co  (BJSE:920656) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Zhejiang Chemsyn Pharm Co Marketable Securities Related Terms

Zhejiang Chemsyn Pharm Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Zhejiang Chemsyn Pharm Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Chemsyn Pharm Co Marketable Securities Chart

Zhejiang Chemsyn Pharm Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 0.00 0.00 0.00 55.22

Zhejiang Chemsyn Pharm Co Quarterly Data
Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.00 360.00 55.22 0.00 0.00
BJSE:920656
61GF Score
Zhejiang Chemsyn Pharm Co Ltd BJSE:920656
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zhejiang Chemsyn Pharm Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ¥0.0 Mil mean?
Zhejiang Chemsyn Pharm Co (BJSE:920656) has a Marketable Securities of ¥0.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Zhejiang Chemsyn Pharm Co and its competitors.
Is Zhejiang Chemsyn Pharm Co's Marketable Securities too high?
Zhejiang Chemsyn Pharm Co's current Marketable Securities is ¥0.0 Mil. Overall, Zhejiang Chemsyn Pharm Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhejiang Chemsyn Pharm Co's Marketable Securities compare to UNH and CVS?
Zhejiang Chemsyn Pharm Co's Marketable Securities of ¥0.0 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Plans company?
A good Marketable Securities depends on the Healthcare Plans industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Zhejiang Chemsyn Pharm Co and its competitors. Zhejiang Chemsyn Pharm Co's current Marketable Securities is ¥0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhejiang Chemsyn Pharm Co stock overvalued right now?
Based on GuruFocus' analysis, Zhejiang Chemsyn Pharm Co (BJSE:920656) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.11, compared to a current price of ¥15.28 — trading 20% below its estimated fair value. The current Marketable Securities is ¥0.0 Mil. Zhejiang Chemsyn Pharm Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Zhejiang Chemsyn Pharm Co (BJSE:920656), the current Marketable Securities is ¥0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zhejiang Chemsyn Pharm Co (BJSE:920656) Overvalued in 2026?

Based on GuruFocus' analysis, Zhejiang Chemsyn Pharm Co stock appears to be undervalued. The current stock price of ¥15.28 is trading 20% below its estimated GF Value™ of ¥19.11. GuruFocus considers Zhejiang Chemsyn Pharm Co to be Modestly Undervalued.

Key valuation signals for BJSE:920656:

  • Marketable Securities: ¥0.0 Mil
  • GF Value™: ¥19.11 vs. price of ¥15.28 (20% below fair value)
  • GF Score™: 61/100 with 3 warning signs

No single metric tells the full story. See the BJSE:920656 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhejiang Chemsyn Pharm Co Business Description

Address Huayang Road, No. 36, High-tech Industrial Park, Zhejiang Province, Quzhou, CHN
Zhejiang Chemsyn Pharm Co Ltd is engaged in Research, development, production and sales of veterinary drug raw materials, pharmaceutical raw materials and intermediates.
61GF Score

Get the complete analysis for BJSE:920656

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.28
Price
¥19.11
GF Value